Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ADMA BIOLOGICS, INC. chart...

About the Company

We do not have any company description for ADMA BIOLOGICS, INC. at the moment.

Exchange

Nasdaq

$258M

Total Revenue

302

Employees

$1B

Market Capitalization

-60.33

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ADMA News

3 'Buy-Rated' Biotech Stocks Under $10

1d ago, source:

All three small-cap biotech/biopharma stocks have attractive risk/reward profiles and potential catalysts on the horizon.

Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?

19d ago, source: Zacks.com on MSN

ADMA Biologics has a Zacks Rank #1 (Strong Buy). In the past 60 days, estimates for ADMA Biologics’ 2024 earnings per share ...

Investors in ADMA Biologics (NASDAQ:ADMA) have seen splendid returns of 261% over the past three years

28d ago, source: Yahoo Finance

For instance the ADMA Biologics, Inc. (NASDAQ:ADMA) share price is 261% higher than it was three years ago. Most would be happy with that. It's also good to see the share price up 45% over the ...

ADMA Biologics, Inc.

2mon ago, source: CNN

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the ...

ADMA Biologics Inc ADMA

2d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

ADMA Biologics Inc

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ADMA Biologics Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...